#$%^&*AU2018202643A120180510.pdf#####ABSTRACT The present invention provides antigen-binding molecules containing (i) an antigen binding domain whose antigen-binding activity varies depending on ion concentration conditions, (ii) an Fcy-binding domain having Fey RIlb-selective binding activity, 5 and (iii) an FcRn-binding domain having FcRn-binding activity under an acidic pH range condition, and methods of decreasing plasma antigen concentration as compared to before administering the molecule, which include the step of administering the molecule.